G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Clinical trial NCT05453552 · UNKNOWN

Trial details

NCT number: NCT05453552
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Allogeneic Hematopoietic Stem Cell Transplantation Conditioning

Start date: 2022-07-01
Primary completion: 2023-12-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.